These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5692083)

  • 1. Hexobarbitone response in barbitone-dependent and withdrawn rats.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1968 Sep; 34(1):210P-211P. PubMed ID: 5692083
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic drug-metabolising enzyme activity and duration of hexobarbitone anaesthesia in barbitone-dependent and withdrawn rats.
    Stevenson IH; Turnbull MJ
    Biochem Pharmacol; 1968 Nov; 17(11):2297-305. PubMed ID: 5752725
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance experiments with barbitone-dependent rats.
    Turnbull MJ; Stevenson IH
    J Pharm Pharmacol; 1968 Nov; 20(11):884-5. PubMed ID: 4387501
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of brain sensitivity and hepatic metabolism of hexobarbitone to dose-response relations in infant and young rats.
    Kalser SC; Forbes E; Kunig R
    J Pharm Pharmacol; 1969 Feb; 21(2):109-13. PubMed ID: 4388087
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of chronic barbitone administration and withdrawal on the sensitivity of the central nervous system to barbiturate.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1969 Oct; 37(2):502P-503P. PubMed ID: 5388578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of hormones on hexobarbital narcosis of rats].
    Hempel R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(5):413-8. PubMed ID: 4236496
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the mechanism of potentiation of hexenal narcosis by ortho-tolylhydrazide of diethylglycolic acid].
    Bargteĭl BA; Kolla VE
    Farmakol Toksikol; 1969; 32(2):141-3. PubMed ID: 5772134
    [No Abstract]   [Full Text] [Related]  

  • 8. The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1970 Jun; 39(2):325-33. PubMed ID: 5463901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altitude-induced alterations in drug action and metabolism.
    Merritt JH; Medina MA
    Life Sci; 1968 Nov; 7(21):1163-9. PubMed ID: 5712728
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of exposure to lindane on drug metabolism: decreased hexobarbital sleeping-times and increased antipyrine disappearance rate in rats.
    Kolmodin-Hedman B; Alexanderson B; Sjöqvist F
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):299-307. PubMed ID: 4109017
    [No Abstract]   [Full Text] [Related]  

  • 11. An investigation of the decrease in the metabolism of hexobarbital, aminopyrine and p-nitrobenzoic acid by liver from rats bearing a pituitary mammotropic tumor.
    Wilson JT
    J Pharmacol Exp Ther; 1968 Mar; 160(1):179-88. PubMed ID: 5639103
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute tolerance to barbiturate in the rat.
    Turnbull MJ; Watkins JW
    Eur J Pharmacol; 1976 Mar; 36(1):15-20. PubMed ID: 944131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation-related changes in tolerance development to hexobarbital after short term treatment with diazepam in the rat.
    Korkmaz S; Carlsson S; Wahlström G
    Brain Res; 1993 Jan; 600(2):345-8. PubMed ID: 8435757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of hepatic drug metabolism in calcium deficiency.
    Dingell JV; Joiner PD; Hurwitz L
    Biochem Pharmacol; 1966 Jul; 15(7):971-6. PubMed ID: 5967908
    [No Abstract]   [Full Text] [Related]  

  • 17. The interaction between spontaneous convulsions and tolerance to hexobarbital in the abstinence after chronic barbital treatments in the rat.
    Wahlström G
    Life Sci; 1976 Dec; 19(12):1817-26. PubMed ID: 1034185
    [No Abstract]   [Full Text] [Related]  

  • 18. [Half-life of hexobarbital and zoxazolamine in rodents. 2-In the rat].
    Buchel L; Absil J; Murawsky M
    C R Seances Soc Biol Fil; 1974; 168(2-3):265-70. PubMed ID: 4282286
    [No Abstract]   [Full Text] [Related]  

  • 19. 18. Cellular adaptation in the development of tolerance to drugs.
    Axelrod J
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():247-64. PubMed ID: 5749387
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between manganese and phenobarbital on hexobarbital hypnosis in the male rat.
    Deimling MJ; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):165-8. PubMed ID: 6622829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.